SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

X4 Pharmaceuticals Q2 EPS $(0.76) Misses $(0.72) Estimate

X4 Pharmaceuticals (NASDAQ:XFOR) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.72) by 5.56 percent. This is a 25.49 percent increase over losses of $(1.02) per share

Benzinga · -
X4 Pharmaceuticals (NASDAQ: XFOR) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.72) by 5.56 percent. This is a 25.49 percent increase over losses of $(1.02) per share from the same period last year.